Launching a drug development company with novel technology from academia
Our corporate group has worked with hundreds of entrepreneurs at this stage to help them optimally and efficiently select and form the appropriate legal entity
Faber has deep experience counseling a significant number of the most prominent U.S.-based life science venture capital and private equity firms. Our experience is broad, and we routinely guide investor clients on seed and later-stage financing transactions, new company incubation activities, and strategic transactions and exits impacting portfolio companies.
In each case, the Faber deal team brings to bear its deep experience serving as outside general or transactional counsel to its discovery and clinical stage therapeutic and other life science companies.
This site uses cookies. Some provide anonymous analysis of how our website is used and some are essential to make the website work. Other cookies enable personalized services or social media features to be used. By using our website, you agree to the use of cookies. To find out more, please see our Privacy Policy. You can disable cookies at any time by changing your browser settings.